Table 2 Predictive factors for overall complications at 30 post-operative days.
Univariable analysis | Multivariable analysis | |||||
---|---|---|---|---|---|---|
OR | 95% CI | p value | Adjusted OR | 95% CI | p value | |
Age > 70 years | 1.65 | 0.57–4.79 | 0.361 | |||
Gender (female) | 0.74 | 0.28–2.01 | 0.561 | |||
BMI > 25 kg/m2 | 1.12 | 0.35–2.48 | 0.807 | |||
ASA III/IV | 0.93 | 0.19–1.7 | 0.882 | |||
WHO performance > 0 | 2.15 | 0.64–7.28 | 0.218 | |||
Active smoking | 1.54 | 0.49–4.8) | 0.465 | |||
Diabetes | 0.80 | 0.25–2.60 | 0.711 | |||
Malignant tumor | 0.69 | 0.15–3.20 | 0.633 | |||
Neoadjuvant Chemotherapy | 1.42 | 0.02–11.71 | 0.745 | |||
Soft pancreatic texture | 1.64 | 0.61–4.42 | 0.331 | |||
Non-dilated pancreatic main duct | 4.54 | 1.41–14.63 | 0.011 | 5.32 | 1.59–17.78 | 0.007 |
Length surgery > 300 min | 1.54 | 0.60–3.96 | 0.372 | |||
Intraoperative blood loss > 400 ml | 1.18 | 0.45–3.08 | 0.738 | |||
Venous resection | 0.84 | 0.28–2.51 | 0.748 | |||
IV POD 0 ≥ 4400 ml | 4.82 | 1.74–13.33 | 0.002 | 4.40 | 1.47–13.19 | 0.008 |